Diagnostic Hybrids Ranks No. 219 On Inc. 500 List Of The Fastest Growing U.S. Companies

Monday Nov 08, 2004
Athens, Ohio

Diagnostic Hybrids Inc., the world?s largest cell culture provider, has ranked No. 219 on Inc. Magazine?s 23rd annual Inc.500 list of the fastest growing, privately-held companies in the nation.

DHI is the only biomanufacturing company to earn a place on the list and the only company among its fellow honorees from Ohio?s Appalachian Region of the United States. DHI revenue has grown consistently with an average annual growth of 165 percent from 2000 through 2003 and an overall growth rate of 663 percent growth during this period on revenues of $17.1 million in 2003. This revenue performance catapulted DHI to the seventh highest ranking of the 17 Ohio companies to make the 2004 list.

Founded in 1983, DHI develops and manufactures genetically engineered tissue cell cultures, monoclonal antibody kits and biological reagents for hospital and commercial laboratories. Located Ohio University Research and Enterprise Park in Athens, DHI currently employs 130 people.